𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Magnetic resonance imaging of breast cancer: Clinical indications and breast MRI reporting system

✍ Scribed by Debra M. Ikeda; Douglas R. Baker; Bruce L. Daniel


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
88 KB
Volume
12
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Computerized measurement of magnetic res
✍ Paul Bird; Marissa Lassere; Ron Shnier; John Edmonds πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 208 KB πŸ‘ 2 views

## Abstract ## Objective One of the major aims of therapy in rheumatoid arthritis (RA) is to prevent erosive disease and subsequent disability. One of the important goals of therapy assessment must therefore be the accurate measurement of damage progression. We undertook this study to assess the f

Magnetic resonance imaging to detect bon
✍ Guenter Layer; Andreas Steudel; Heinrich SchΓΌller; Gerhard van Kaick; Frank GrΓΌn πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Background: Bone marrow is a common site of metastases in patients with small cell lung carcinoma (sclc) and female breast carcinoma (fbc). metastatic bone marrow involvement is found in approximately 50% of sclc patients and up to 85% of fbc patients at autopsy. initial staging procedures detec

Clinical application of BASING and spect
✍ Ryan G. Males; Daniel B. Vigneron; Josh Star-Lack; Stephen C. Falbo; Sarah J. Ne πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 198 KB πŸ‘ 2 views

In previous in situ point-resolved spectroscopy (PRESS) three-dimensional (3D) 1H magnetic resonance (MR) spectroscopic imaging studies, it has been demonstrated that the ratio of prostatic metabolites can noninvasively discriminate prostate cancer from surrounding normal tissue. However, in these s

Clinical trial of Ξ”1-testololactone (NSC
✍ Ira S. Goldenberg πŸ“‚ Article πŸ“… 1969 πŸ› John Wiley and Sons 🌐 English βš– 329 KB πŸ‘ 1 views

A'-TESTOLOLACTONE (NSC 23759), MEDROXY PROGESTERONE ACETATE (NSC 26386) AND OXYLONE ACETATE (NSC 47438) I N ADVANCED FEMALE MAMMARY CANCER A Reil,ort of the Cooperative Byeast Cancer G ~u ~I REPORT PREPARED HY IRA S. GOI-DEKHERG, MD Three hundred and nineteen women with advanced and metastatic carci